Wildcat Capital Management, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 14, 2024), Wildcat Capital Management, LLC reported 16 stock positions worth $275.5 million. Its top holding was Frontier Communications Pare (FYBR) at 12.5% of the portfolio, followed by Goosehead Insurance Class A (GSHD, 12.5%) and Moody's (MCO, 11.7%). Compared with Q4 2023, it opened 1 new position, sold out of 5, added to 1 and reduced 2. The biggest buy was Moody's (MCO, shares +44%) and the biggest sale an exit from Toast Class A (TOST).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001582384
- Portfolio Value
- $275.5M (Q1 2024)
- SEC Filing
- 0001999371-24-006054 ↗ filed May 14, 2024
Holdings Value
Holdings 16 stocks · $275.5M
| FYBR Frontier Communications Pare | 12.48% | 1,412,617 | $34.4M | No change |
| GSHD Goosehead Insurance Inc. Class A | 12.48% | 516,008 | $34.4M | No change |
| MCO Moody's Corp. | 11.73% | 82,208 | $32.3M | Add +43.7% |
| MSFT Microsoft Corp. | 11.45% | 75,000 | $31.6M | No change |
| RLX RLX Technology Inc.-ADR | 11.15% | 18,046,195 | $30.7M | No change |
| GLBE Global-E Online Ltd. | 10.57% | 801,477 | $29.1M | No change |
| DASH DoorDash Inc. Class A | 8.75% | 243,683 | $24.1M | No change |
| META Meta Platforms Inc. Class A | 8.60% | 48,814 | $23.7M | Reduce -31.1% |
| ALLO Allogene Therapeutics Inc. | 2.86% | 1,920,787 | $7.9M | No change |
| URGN Urogen Pharma Ltd. | 2.70% | 495,606 | $7.4M | No change |
| CONSOLIDATED COMM HLDGS INC | 2.34% | 1,494,447 | $6.5M | Reduce -50.2% |
| SKILLZ INC | 2.31% | 979,848 | $6.4M | No change |
| COIN Coinbase Global Inc. Class A | 1.65% | 17,169 | $4.6M | No change |
| KRON Kronos Bio Inc. | 0.61% | 1,297,959 | $1.7M | No change |
| NMRA Neumora Therapeutics Inc. | 0.27% | 54,894 | $755K | New |
| AKLI Akili Inc. | 0.06% | 545,295 | $158K | No change |
Portfolio Sells Q4 2023 → Q1 2024
| TOST Toast Inc. Class A | Sold out | 0.00% | −2.82 |
| CONSOLIDATED COMM HLDGS INC | Reduce -50.2% | 2.34% | −2.17 |
| PRAX Praxis Precision Medicines I | Sold out | 0.00% | −0.13 |
| DDOG Datadog Inc. Class A | Sold out | 0.00% | −0.12 |
| META Meta Platforms Inc. Class A | Reduce -31.1% | 8.60% | −0.06 |
| BRZE Braze Inc. Class A | Sold out | 0.00% | −0.04 |
| NRDY Nerdy Inc. | Sold out | 0.00% | −0.03 |
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $228.5M | ULCC, ALLO, CHYM |
| Q1 2026 | 2 | $106.2M | ULCC, ALLO |
| Q4 2025 | 3 | $136.5M | ULCC, ALLO, PCOR |
| Q3 2025 | 5 | $145.1M | ULCC, RLX, ALLO, TTAN, GTLB |
| Q2 2025 | 6 | $168.3M | ULCC, RLX, TIC, URGN, ALLO |
| Q1 2025 | 8 | $187.4M | ULCC, RLX, TIC, URGN, ALLO |
| Q4 2024 | 8 | $252.7M | ULCC, RLX, ALLO, URGN, KRON |
| Q3 2024 | 7 | $204.6M | ULCC, RLX, ALLO, URGN, SKILLZ INC |
| Q2 2024 | 16 | $408.6M | ULCC, FYBR, MCO, MSFT, RLX |
| Q1 2024 | 16 | $275.5M | FYBR, GSHD, MCO, MSFT, RLX |